title: Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.
authors.forename: Jan G
authors.initials: JG
authors.lastname: den Hollander
authors.forename: Bart J
authors.initials: BJ
authors.lastname: Rijnders
authors.forename: Gerard J J
authors.initials: GJ
authors.lastname: van Doornum
authors.forename: Marchina E
authors.initials: ME
authors.lastname: van der Ende
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000150:complications / Q000235:genetics* / Q000635:transmission; D018451:Homosexuality, Male; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D047568:Unsafe Sex
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a